Hologic launches TempSure Surgical RF tech in North America

Hologic, Inc has launched TempSure Surgical RF technology in North America.
The TempSure radiofrequency (RF) platform provides clinicians the ability to perform both surgical and non-surgical aesthetic procedures across a variety of specialties, on a single device.
TempSure Surgical RF technology harnesses a 300-watt and 4-MHz radiofrequency platform that enables precise incisions with minimal lateral thermal damage to the surrounding tissues. The resulting high-quality coagulation lessens sparking and charring during procedures, which promotes quicker recovery and better healing for patients.
TempSure Surgical RF technology includes a variety of electrodes that integrate seamlessly with the main TempSure unit. In January 2018, Cynosure, a Hologic arm, launched the TempSure radiofrequency platform with TempSure Envi, a device for treating facial fine lines and wrinkles, tightening the skin through soft tissue coagulation, and temporarily reducing the appearance of cellulite.